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Abstract
Background: Our past studies have shown that cigarette smoke inhibits oviductal functioning in
vivo and in vitro. The goals in this study were to identify pyrazine derivatives in cigarette smoke
solutions that inhibit ciliary beat frequency, oocyte pickup rate, and infundibular smooth muscle
contraction in the hamster oviduct and to determine their lowest observable adverse effect levels
(LOAELs) using in vitro bioassays.
Methods: MS smoke solutions were fractionated using solid phase extraction cartridges and the
fractions were both tested on the hamster oviduct in vitro and analyzed by gas chromatography-
mass spectrometry to identify individual pyrazine derivatives. Commercial pyrazine standards were
purchased, assayed for purity, and tested in dose-response studies on hamster oviducts. The
LOAEL and efficacy were determined for each compound in the in vitro bioassays. Statistical
significance was determined using the Student's t-Test where p < 0.05.
Results: The LOAELs for the most inhibitory pyrazine derivatives in the ciliary beat frequency,
oocyte pickup rate, and infundibular smooth muscle contraction assays w e r e  a s  f o l l o w s :  f o r
pyrazine (1 picomolar, 10 picomolar, and 1 nanomolar); for 2-methylpyrazine (1 picomolar, 10
picomolar, and 10 picomolar); and for 2-ethylpyrazine (1 picomolar, 10 picomolar, and 1
picomolar). Six of the seven pyrazine derivatives tested (pyrazine, 2-methylpyrazine, 2-
ethylpyrazine, 2-methoxy-3-methylpyrazine, 2,5-dimethylpyrazine, and 2,3,5-trimethylpyrazine)
were inhibitory in picomolar or nanomolar doses in all three bioassays, while the seventh
derivative, 2,6-dimethylpyrazine, had LOAELs in the nanomolar to micromolar range.
Conclusion:  This work shows that very low doses of pyrazines significantly inhibit proper
oviductal functioning, raising questions regarding the safety of these compounds in cigarettes and
other consumer products.
Background
The mammalian oviduct plays important roles in repro-
duction. After an oocyte cumulus complex (OCC) is ovu-
lated from the ovary into the peritoneal or bursal cavity, it
is "picked-up" by the infundibular portion of the oviduct
[1,2]. As the OCC adheres to the ciliated outer surface of
the infundibulum [3], cilia beat in the direction of the
ostium. Both adhesion and ciliary beating are needed to
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move the OCC into the ampulla, where fertilization
occurs [4-6]. Failure of the OCC to be properly picked-up
by the oviduct can result in ectopic pregnancy [7]. Ciliated
epithelial cells also line the lumen of the oviduct, where
they function in transport of preimplantation embryos
through the oviduct [2,8]. Oviductal smooth muscle con-
traction also plays a role in transporting the embryo
towards the uterus [2,9-16].
There is both in vivo and in vitro evidence that the mam-
malian oviduct is a target of cigarette smoke. Oviducts can
be exposed either directly to mainstream (MS) smoke,
which is the smoke inhaled by active smokers, or indi-
rectly to sidestream (SS) smoke, which burns off the end
of cigarettes. Inhalation of MS and SS cigarette smoke by
hamsters was correlated with blebbing of ciliated epithe-
lial cells and a decreased ratio of ciliated to secretory cells
in the ampulla of the oviduct [17]. MS and SS smoke inha-
lation by hamsters also slowed oviductal smooth muscle
contraction and embryo transport [18]. These effects were
seen when the inhaled doses of MS and SS smoke were
similar to those received by active and passive smokers as
measured by serum cotinine levels [17,18]. In humans,
inhalation of cigarette smoke also inhibited oviductal
muscle contraction [19].
Intravenous administration of nicotine, a major compo-
nent of cigarette smoke, retarded rat embryo cleavage,
reduced embryo cell number, and reduced oviductal
blood flow [20], which may be related to reduced smooth
muscle contraction [21]. Intravenous nicotine also inhib-
ited oviductal motility in Rhesus monkeys [22].
A newly developed in vitro assay has been useful in study-
ing the effects of smoke exposure on hamster oviductal
functioning [4,5,8,16,23-25]. MS and SS cigarette smoke
solutions significantly decreased ciliary beat frequency,
oocyte pickup rate, and oviductal smooth muscle contrac-
tion in hamster oviducts in vitro; however, in the presence
of albumin, SS smoke solutions stimulated ciliary beat fre-
quency [5,8,16,23,25]. Individual MS and SS smoke con-
stituents (potassium cyanide, acrolein, phenol,
acetaldehyde, and formaldehyde), which are ciliotoxic in
other models, inhibited oocyte pickup rate and ciliary
beat frequency [26]. However, only cyanide was present in
cigarette smoke solutions in a high enough concentration
to account for the effect seen in vitro [26].
To test the hypothesis that additional ciliotoxic chemicals
are present in smoke, we fractionated MS smoke solutions
using solid phase extraction cartridges. Twelve pyridine
and seven pyrazine compounds were then identified in
the active fractions using gas chromatography-mass spec-
trometry (GC-MS) [16]. We previously showed that sev-
eral of the pyridines inhibited the ciliary beat frequency,
oocyte pickup rate, and infundibular smooth muscle con-
traction rate at picomolar doses [16]. The purpose of the
present study was to test the hypothesis that the pyrazine
derivatives identified in active smoke fractions also inhib-
ited oviductal functioning. Dose-response experiments
were used to determine the lowest observable adverse
effect level (LOAEL) and efficacy of each pyrazine deriva-
tive on ciliary beat frequency, oocyte pickup rate, and
infundibular smooth muscle contraction. Our data show
that the pyrazine derivatives, some of which are widely
used in consumer products, inhibit oviductal functioning
in the picomolar to nanomolar range.
Methods
Animals
Female golden hamsters (Mesocricetus auratus) purchased
from Harlan Sprague Dawley (San Diego, CA) were main-
tained on a 14L:10D cycle in a room at 26°C. Food was
administered ad libitum. Hamsters were cycled daily by
checking for a vaginal discharge, which occurs on day 1 of
their estrous cycle [27]. Female golden hamsters were
induced to ovulate by intraperitoneal injection with 25 IU
of pregnant mare's serum gonadotropin (PMSG) (CalBio-
chem, La Jolla, CA.) at 10 AM on day 1 of their estrous
cycle, followed by 25 IU of human chorionic gonadotro-
pin (hCG) (Sigma Chemical Co., St. Louis, MO) on day 3
of their estrous cycle, and used twelve hours later on day
4 for all experiments. One animal was injected and used
on any given day for an experiment. Unfertilized follicular
oocytes were collected by a method previously described
[16]. The protocol for the use of hamsters in this study was
approved by the campus animal use committee.
Media and chemical standards
Oocyte pickup rate, ciliary beat frequency, and infundibu-
lar smooth muscle contraction assays were done in 1x
Earle's Balanced Salt Solution (EBSS-H) supplemented
with sodium bicarbonate, HEPES, and 0.1% BSA [23]. The
pH was adjusted to 7.4 with NaOH. This solution was
used for dissection, incubation, and as the control solu-
tion for all experiments. Pyrazine (99+ %), 2-methylpyra-
zine (99+ %), 2,5-dimethylpyrazine (98%), 2,6-
dimethylpyrazine (98%), 2,3,5-trimethylpyrazine (99%),
2-ethylpyrazine (98%), and 2-methoxy-3-methylpyrazine
(99%) were purchased from Aldrich Chemical Company
(Milwaukee, WI).
Preparation of smoke solutions
MS smoke solutions were made in EBSS-H using 2R1
research-grade cigarettes (University of Kentucky, Louis-
ville, KY) that were smoked on a puffer box built at the
University of Kentucky [23,25]. Diagrams showing the
arrangement of the puffer box and vacuum pumps have
been published previously [25]. The MS was adjusted to a
pH of 7.4 and 0.1% BSA was added. MS smoke solutionsReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/23
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were made from 60 puffs of MS smoke pushed through 10
ml of EBSS-H, which is equal to 6 puffs/ml and is defined
as 6 puff equivalents per millilitre [16,23,25].
Solid phase extraction of smoke solutions
Bond Elut solid phase extraction (SPE) cartridges, 3 cc,
500 g capacity (Phenomenex, Torrance, CA) were used to
fractionate smoke solutions and concentrate chemicals
that inhibit oviductal functioning. Cartridges which were
screened for their ability to bind inhibitory chemicals
included a variety of non-polar, polar, and anion and cat-
ion exchange cartridges: NH2, 2OH, CN, CBA, SCX, SAX,
C18, C8, C2, CH, SI, and PH. The protocol used to screen
the cartridges for their ability to bind oviductal toxicants
in smoke solutions has been described previously [16].
Gas chromatography-mass spectrometry (GC-MS)
The C8, PH, and CN cartridges retained most of the inhib-
itory activity in MS smoke solutions as determined in the
oviductal assays. To identify the components in aqueous
smoke solutions that inhibit oviductal functioning, MS
smoke solutions were analyzed with GC-MS after solid
phase extraction on a C8, PH, or CN cartridge and elution
with methanol. Two microliters of each sample was
injected into a Hewlett Packard 5890 GC interfaced to an
HP-5971A MSD quadrupole mass selective detector with
a Zebron ZB1701 cyanopropyl phenyl column 30 m ×
0.32 mm with 1 micron phase thickness from Phenom-
enex (Torrance, CA.) as described previously [16]. Identi-
fications of compounds were made using the mass
spectrometry data matched to mass spectral library
entries. Compound identities were confirmed using puri-
fied standards and matching both mass spectra and reten-
tion times.
Oocyte pickup rate assay
For this assay, one hamster was injected with 25 IU of
PMSG on day 1 of the estrous cycle, followed by 25 IU of
hCG on day 3. On the day of the experiment, approxi-
mately 12 hours after the injection of hCG, the hamster
was sacrificed using CO2, and two oviducts and ovaries
were removed and separated. The two ovaries were iso-
lated in EBSS-H with 0.1% BSA, and expanded follicles
were poked with a dissecting needle to release the oocyte
cumulus complexes (OCCs). Approximately 7–15 mature
expanded OCCs were recovered from each ovary. OCCs
were transferred to a fresh Petri dish and placed in EBSS-
H with 0.1% BSA. Two infundibula were dissected from
the oviducts leaving the ampullas attached to function as
handles. The infundibula were placed in perfusion cham-
bers containing EBSS-H with 0.1% BSA, and the ampullas
were placed into the holding pipettes so the infundibula
remained stationary throughout the experiment. Oocyte
pick-up rate was measured using hamster oviduct explants
in an in vitro assay developed in our lab [4,16,25,26].
Using a Wild 5A stereoscopic microscope, an OCC was
placed onto the infundibulum, and the length of time for
the OCC to traverse a defined path was recorded. This
defined path was used for both the control and treatment
groups. A total of six to ten measurements were made and
the means ± standard deviations were calculated for each
treatment group. A single experiment was defined as the
treatment of a single infundibulum with the control
medium (EBSS-H with 0.1% BSA), and a single dose of
the test chemical diluted in EBSS-H with 0.1% BSA.
Ciliary beat frequency assay
Ciliary beat frequency was measured using hamster ovi-
ductal explants in an in vitro assay developed in our lab
[23,25,26]. A video image capture system was used to
measure ciliary beat frequency as described previously
[16]. Infundibula were placed on a Wild M5A stereoscopic
microscope, and a video image was captured using an
Hitachi KP-D50 color digital camera and viewed on a Dell
Optiplex GXA computer. Images of the beating cilia were
recorded onto a Super VHS videotape using a Sony Hi-Fi
SVHS recorder. To measure ciliary beat frequency, the vid-
eotape was played back frame-by-frame. Video images
were recorded at 30 frames per second. Each frame repre-
sented a fraction of a cycle; the completion of a cycle was
equivalent to one beat. The number of frames per cycle (or
frames per beat) were measured and then converted into
beats per second. A single experiment was defined as the
treatment of a single infundibulum with the control
medium (EBSS-H with 0.1% BSA) and a single dose of the
test chemical diluted in EBSS-H with 0.1% BSA. Ten meas-
urements were made for each infundibulum for each
treatment group. Recordings were made for 60 to 150 sec-
onds per region, which ensured an adequate amount of
data for analysis. The same region was recorded for both
the control and treated groups.
Infundibular muscle contraction assay
A new assay for measuring infundibular muscle contrac-
tion was developed in our lab after observing consistent
infundibular contractions that slowed or ceased after
treatment with MS smoke solutions [16]. A single experi-
ment was defined as the treatment of a single infundibu-
lum with the control medium (EBSS-H with 0.1% BSA)
and a single dose of the test chemical diluted in EBSS-H
with 0.1% BSA. A perfusion chamber containing the
infundibulum was placed on a Wild M5A stereoscopic
microscope, and a video image was captured using an
Hitachi KP-D50 color digital camera and viewed with a
Dell Optiplex GXA computer and an NEC Multisync 5FG
monitor. Infundibular contractions were observed and
measured directly on the computer monitor. As the
infundibulum contracted, the distance of the contraction
was measured in centimeters and then converted to
micrometers as described previously [16]. For eachReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/23
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experiment, distance and frequency were measured six
times for a single infundibulum per treatment group (the
control medium EBSS-H with 0.1% BSA and a single dose
of the test chemical diluted in EBSS-H with 0.1% BSA).
The perfusion chamber was equipped with a pipette that
held the ampulla of the oviduct in place facilitating the
ability to return to the same region for both the control
and treatment measurements. For the infundibular
smooth muscle contraction assay, the same region was
observed and the same direction of contraction was used
for both the control and treatment groups.
Statistical analysis
To determine LOAELs for each pyrazine derivative in each
bioassay, two levels of analysis were performed. First, a
preliminary screen of the pyrazine compounds was done
using a single infundibulum per dose group (10-13–10-5
M). For each infundibulum, 6–10 control, treatment, and
recovery measurements were taken, and the means were
compared using a one-way ANOVA. The lowest significant
inhibitory dose provided an estimate of the LOAELs for
each pyrazine derivative in each assay.
Since the estimated LOAELs were based on only one
infundibulum per dose, additional experiments were per-
formed at the estimated LOAEL doses to increase the sam-
ple size to n = 4 infundibula for each pyrazine derivative
in each bioassay. The statistical significance of these
results was evaluated using Student's t-Test to compare the
mean of the control (n = 4 infundibula) to the mean at the
estimated LOAEL dose (n = 4 infundibula) for each pyra-
zine derivative in each bioassay (Figs. 1,2,3,4,5,6,7). MS
Excel 2002 (Microsoft Corp, Redmond, WA.) was used for
all statistical analysis. Means were considered to be signif-
icantly different for p < 0.05.
To analyze the efficacies of each pyrazine derivative rela-
tive to the parent compound pyrazine, each derivative was
treated as a separate experiment, and statistical analyses
were performed by comparing the percent inhibition of
the derivative (n = 4 infundibula) to the percent inhibi-
tion of pyrazine (n = 4 infundibula) at the LOAEL doses
using Student's t-Test. These statistics are reported in Table
2.
Results
Pyrazines identified in the active fractions of MS smoke 
solutions
When MS cigarette smoke solution was passed through
twelve solid phase extraction cartridges, the CN, PH, and
C8 cartridges were the most effective at retaining the com-
pounds responsible for the inhibition of ciliary beat fre-
quency, oocyte pickup rate, and infundibular smooth
muscle contraction [16]. Pyrazine derivatives were identi-
fied by gas chromatography-mass spectrometry (GC-MS)
as a predominant class of compounds that were retained
by these cartridges, and the specific pyrazines in the active
fractions of MS smoke solutions are shown for each car-
tridge in Table 1. 2-Methylpyrazine was the most abun-
dant in the cartridge eluates. Commercially available
standards of the identified pyrazines (2-methylpyrazine,
2,5-dimethylpyrazine, 2,6-dimethylpyrazine, 2,3,5-tri-
methylpyrazine, 2-ethylpyrazine, and 2-methoxy-3-meth-
ylpyrazine) were purchased and tested in dose-response
studies on the oviduct to determine their effect on ciliary
beat frequency, oocyte pickup rate, and infundibular mus-
cle contraction. In addition, pyrazine, which was not
found in the cartridge eluates, was also purchased and
tested to compare the parent compound to derivatives
with methyl, ethyl, or methoxy substitutions on the pyra-
zine ring. The results from the dose-response experiments
are reported for each compound in Figures 1,2,3,4,5,6,7
and are summarized in Table 2.
Pyrazine inhibits oviductal functioning at picomolar or 
nanomolar doses in all three assays
Pyrazine inhibited ciliary beat frequency and oocyte
pickup rate at picomolar doses and infundibular smooth
muscle contraction at nanomolar doses when compared
to the control, which was treated with the vehicle (EBSS-
H with 0.1% BSA) alone (Fig. 1). Significant inhibition of
ciliary beat frequency, oocyte pickup rate, and infundibu-
lar smooth muscle contraction occurred at 10-12 M, 10-11
M, and 10-9 M, respectively, which were the lowest observ-
able adverse effect levels (LOAELs) (Fig. 1, Table 2). The
efficacy for all three oviductal assays was determined
using the percent inhibition at the LOAEL. The efficacies
in the ciliary beat frequency, oocyte pickup rate, and
infundibular smooth muscle contraction assays were
25%, 29%, and 40%, respectively (Table 2).
Pyrazines with single ethyl or methyl substitutions are 
potent in picomolar doses in all three assays
Pyrazine compounds with single methyl (2-methylpyra-
zine) or single ethyl (2-ethylpyrazine) substitutions had
LOAELs in the picomolar range for all three bioassays
(Figs. 2, 3). For 2-methylpyrazine, the LOAELs were 10-12
M, 10-11 M, and 10-9 M in the ciliary beat frequency, oocyte
pickup rate, and infundibular smooth muscle contraction
assays, respectively (Fig. 2, Table 2). For 2-ethylpyrazine,
the LOAELs were 10-12 M, 10-11 M, and 10-12 M in the cili-
ary beat frequency, oocyte pickup rate, and infundibular
smooth muscle contraction rate assays, respectively (Fig.
3, Table 2). While the LOAELs for ciliary beat frequency
and oocyte pickup rate did not change relative to pyrazine
for these two derivatives, the LOAELs in the smooth mus-
cle contraction assay decreased 100 and 1000-fold,
respectively for 2-methylpyrazine and 2-ethylpyrazine
(Figs. 2, 3, Table 2).Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/23
Page 5 of 14
(page number not for citation purposes)
In most cases, single methyl and single ethyl substitutions
on pyrazine altered the efficacies when compared to pyra-
zine alone. For both 2-methyl and 2-ethylpyrazine, the
efficacies for the ciliary beat frequency assay were signifi-
cantly lower than for pyrazine alone, while efficacies for
these two compounds significantly increased relative to
pyrazine in the oocyte pickup rate assay (Table 2). In the
infundibular smooth muscle contraction assay, the single
ethyl substitution did not have a significant effect on effi-
cacy, while the single methyl substitution significantly
increased efficacy compared to pyrazine (Table 2).
Dimethyl substituted pyrazines, in general, are less potent 
than single methyl substituted pyrazines
In general, the dimethylpyrazines were less potent than
the single ethyl or methyl substituted pyrazines or pyra-
zine alone. 2,5-Dimethylpyrazine had LOAELs equivalent
to pyrazine in the oocyte pickup rate (10-11  M) and
infundibular smooth muscle contraction rate (10-9 M)
Pyrazine inhibited oviductal functioning at picomolar and nanomolar doses Figure 1
Pyrazine inhibited oviductal functioning at picomolar and nanomolar doses. Percent inhibition was derived by comparing each 
dose (n ≥ 2 infundibula) to an untreated control incubated in the vehicle alone (EBSS-H with 0.1% BSA). Each LOAEL (n = 4 
infundibula) was compared to the untreated control (n = 4) using the Student's t-Test where *p < 0.5; **p < 0.01; ***p < 0.001.
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assays; however, its LOAEL in the ciliary beat frequency
assay (10-8 M) was 10,000 times greater than that of pyra-
zine (10-12 M) (Fig. 4, Table 2). In all cases, 2,5-dimethyl-
pyrazine was more potent than 2,6-dimethylpyrazine,
which inhibited ciliary beat frequency, oocyte pickup rate,
and infundibular smooth muscle contraction with
LOAELs of 10-6 M, 10-9 M, and 10-7 M, respectively (Fig. 5,
Table 2).
2,5-Dimethylpyrazine had the highest efficacy of all the
pyrazine compounds in the ciliary beat frequency assay
(34%), however it was not statistically different from
pyrazine. 2,5-Dimethylpyrazine (9.9%) and 2,6-dimeth-
ylpyrazine (3.5%) had significantly lower efficacies in the
oocyte pickup rate assay compared to pyrazine. 2,6-
Dimethylpyrazine was the least potent of all the com-
pounds tested, however, its efficacy in the infundibular
smooth muscle contraction assay (85%) was significantly
higher than pyrazine (Table 2).
Pyrazines with trimethyl or methoxy-methyl substitutions 
are inhibitory in nanomolar or picomolar doses
For 2,3,5-trimethylpyrazine, the LOAELs were 10-9 M, 10-
10 M, and 10-9 M in the ciliary beat frequency, oocyte
pickup rate, and infundibular smooth muscle contraction
assays, respectively (Fig. 6, Table 2). For the ciliary beat
frequency assay, the LOAEL was lower than the dimethyl
pyrazines, but not as low as the ethyl or methyl substi-
tuted pyrazines or pyrazine alone. For the oocyte pickup
rate assay, the LOAEL was lower than 2,6-dimethylpyra-
zine, but higher than all the other pyrazines. For the
infundibular smooth muscle contraction assay, the
LOAEL was the same as that for pyrazine and 2,5-dimeth-
2-Methylpyrazine inhibited oviductal functioning in picomolar doses Figure 2
2-Methylpyrazine inhibited oviductal functioning in picomolar doses. Percent inhibition was derived by comparing each dose (n 
≥ 2 infundibula) to an untreated control incubated in the vehicle alone (EBSS-H with 0.1% BSA). Each LOAEL (n = 4 infundib-
ula) was compared to the untreated control (n = 4) using the Student's t-Test where *p < 0.5; **p < 0.01; ***p < 0.001.
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ylpyrazine, but higher than the ethyl or methyl substi-
tuted pyrazines.
For 2-methoxy-3-methylpyrazine the LOAELs were 10-9
M, 10-12 M, and 10-12 M, respectively, for the ciliary beat
frequency, oocyte pickup rate, and infundibular muscle
contraction assays (Fig. 7, Table 2). In the oocyte pickup
rate and infundibular smooth muscle contraction rate
assays the LOAELs were the lowest (10-12 M) compared to
all the other pyrazines tested. For the ciliary beat fre-
quency assay, the LOAEL was the same as for the trimethyl
substituted pyrazine (10-9 M).
The efficacies for 2,3,5-trimethylpyrazine (10%) and 2-
methoxy-3-methylpyrazine (13%) for oocyte pickup rate
were significantly lower than for pyrazine alone (Table 2).
The efficacy of 2,3,5-trimethylpyrazine (58%) for the
infundibular smooth muscle contraction rate assay was
significantly higher than for pyrazine. 2-Methoxy-3-meth-
ylpyrazine had the lowest efficacy (17%) in the infundib-
ular smooth muscle contraction assay and was
significantly lower than pyrazine, although its LOAEL is
among the lowest (Table 2). The efficacies for 2,3,5-tri-
methylpyrazine and 2-methoxy-3-methylpyrazine for the
ciliary beat frequency assay were not significantly different
than for pyrazine (Table 2).
2-Ethylpyrazine inhibited oviductal functioning in picomolar doses Figure 3
2-Ethylpyrazine inhibited oviductal functioning in picomolar doses. Percent inhibition was derived by comparing each dose (n ≥ 
2 infundibula) to an untreated control incubated in the vehicle alone (EBSS-H with 0.1% BSA). Each LOAEL (n = 4 infundibula) 
was compared to the untreated control (n = 4) using the Student's t-Test where *p < 0.5; **p < 0.01; ***p < 0.001.
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Discussion
Six pyrazine derivatives containing hydrocarbon substitu-
tions were identified in the active fractions of MS smoke
solutions that were known to inhibit oviductal function-
ing. In the current study, pyrazine and the identified
pyrazine derivatives inhibited ciliary beat frequency,
oocyte pickup rate, and smooth muscle contraction in
hamster oviductal explants. The LOAELs and efficacies for
each compound tested in this study are compared in Table
2 for each of the oviductal assays. The finding that these
pyrazine compounds are inhibitory at very low doses is
significant because of their widespread use as additives in
food and tobacco [28].
The hierarchies of potency of the pyrazine compounds as
determined by the LOAELs in this study for the ciliary beat
frequency, oocyte pickup rate, and infundibular smooth
muscle contraction rate assays are summarized in Table 3.
In all the assays, pyrazine derivatives showed an equal or
greater potency than pyrazine. A previous study that
looked at the effect of pyridine derivatives on ciliary beat
frequency, oocyte pickup rate, and infundibular smooth
muscle contraction found that pyridine derivatives with a
single ethyl substitution and several with a single methyl
substitution were also effective in picomolar doses and
were ten million times more inhibitory than pyridine
alone [16]. The pyrazine ring differs from the pyridine
ring only by the presence of a second nitrogen atom in the
2,5-Dimethylpyrazine inhibited oviductal functioning in nanomolar doses Figure 4
2,5-Dimethylpyrazine inhibited oviductal functioning in nanomolar doses. Percent inhibition was derived by comparing each 
dose (n ≥ 2 infundibula) to an untreated control incubated in the vehicle alone (EBSS-H with 0.1% BSA). Each LOAEL (n = 4 
infundibula) was compared to the untreated control (n = 4) using the Student's t-Test where *p < 0.5; **p < 0.01; ***p < 0.001.
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fourth position of the ring, yet pyrazine was at least 1
million-fold more inhibitory than pyridine in all three
bioassays.
The efficacy of each pyrazine derivative identified in the
cigarette smoke solutions was calculated for ciliary beat
frequency, oocyte pickup rate, and infundibular smooth
muscle contraction rate (Table 2). In all three assays, the
pyrazines with single ethyl or methyl substitutions were
among the most inhibitory at the LOAEL dose. Single
methyl and ethyl substituted pyrazines were always in the
number one or number two position in the hierarchy of
potency (Table 3) for each bioassay irrespective of water
solubility or lipophilicity. In general, pyrazine and its
derivatives were more effective at inhibiting oocyte pickup
rate and infundibular smooth muscle contraction rate
than ciliary beat frequency. A similar pattern was observed
for the pyridine compounds tested previously on oviduc-
tal functioning [16].
We have now discovered two classes of smoke constitu-
ents, pyridines [16] and pyrazines, that are ciliotoxic at
2,6-Dimethylpyrazine inhibited oviductal functioning in nanomolar or higher doses Figure 5
2,6-Dimethylpyrazine inhibited oviductal functioning in nanomolar or higher doses. Percent inhibition was derived by compar-
ing each dose (n ≥ 2 infundibula) to an untreated control incubated in the vehicle alone (EBSS-H with 0.1% BSA). Each LOAEL 
(n = 4 infundibula) was compared to the untreated control (n = 4) using the Student's t-Test where *p < 0.5; **p <0.01; ***p < 
0.001.
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very low doses in vitro. In this study, pyrazine and its deriv-
atives inhibited ciliary beat frequency at doses much
lower than previously shown with cyanide. However,
ciliary beat frequency was only modestly affected by pyra-
zine derivatives compared to oocyte pickup rate. There-
fore, it is probable that pyrazine derivatives inhibited
oocyte pickup rate by affecting another factor(s) in addi-
tion to ciliary beat frequency. We have previously shown
that adhesion of the OCC matrix to the tips of the cilia is
also needed for successful OCC pickup [5]. It is possible
that pyrazine and its derivatives had a stronger effect on
adhesion than on ciliary beat frequency, which could
account for the stronger inhibition of oocyte pickup rate
that we observed. Although our results cannot be extrapo-
lated to humans, epidemiological studies show that
women who smoke are at increased risk for ectopic preg-
nancies and spontaneous abortions [7,12,15,29-31] [40],
two conditions that could be caused by inhibition of
oocyte pickup.
In this study, pyrazine derivatives found in cigarette
smoke also adversely affected smooth muscle contraction
of the infundibular portion of the hamster oviduct in vitro
at nanomolar and picomolar doses. Previously, pyridine
compounds were also shown to inhibit infundibular
smooth muscle contraction at similarly low doses [16].
2,3,5-Trimethylpyrazine inhibited oviductal functioning in nanomolar doses Figure 6
2,3,5-Trimethylpyrazine inhibited oviductal functioning in nanomolar doses. Percent inhibition was derived by comparing each 
dose (n ≥ 2 infundibula) to an untreated control incubated in the vehicle alone (EBSS-H with 0.1% BSA). Each LOAEL (n = 4 
infundibula) was compared to the untreated control (n = 4) using the Student's t-Test where *p < 0.5; **p < 0.01; ***p < 0.001.
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The pyridine and pyrazine data suggest that the inhibition
of infundibular smooth muscle contraction observed in
vitro using MS smoke solutions [16] is due to the pyridine
and pyrazine derivatives found in the smoke solutions.
These individual smoke constituents may also be
responsible for the inhibition of smooth muscle contrac-
tion that was observed in the hamster oviduct after in vivo
inhalation of MS cigarette smoke [18].
In addition to effects on oviductal functioning, the pyra-
zine and pyridine derivatives found in cigarette smoke
impair other biological processes. Six pyrazine and twelve
pyridine derivatives along with their parent compounds
inhibited growth of the chick chorioallantoic membrane
(CAM) [32,33]. Pyrazine was the most potent chemical
tested and inhibited both CAM and embryo growth at
picomolar doses due to inhibition of DNA synthesis [32].
Several pyrazine [32] and pyridine (unpublished data)
derivatives also perturbed pattern formation of blood ves-
sels, migration of mesodermal blood vessels to the ecto-
derm, and differentiation of the capillary plexus in CAMs.
Several pyrazine and pyridine derivatives with single ethyl
2-Methoxy-3-methylpyrazine inhibited oviductal functioning innanomolar and picomolar doses Figure 7
2-Methoxy-3-methylpyrazine inhibited oviductal functioning innanomolar and picomolar doses. Percent inhibition was derived 
by comparing each dose (n ≥ 2 infundibula) to an untreated control incubated in the vehicle alone (EBSS-H with 0.1% BSA). 
Each LOAEL (n = 4 infundibula) was compared to the untreated control (n = 4) using the Student's t-Test where *p < 0.5; **p 
< 0.01; ***p < 0.001.
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or methyl substitutions (3-ethylpyridine, 2-ethylpyridine,
2-methylpyridine, and 2-ethylpyrazine) inhibited CAM
and/or embryo growth [32,33] and oviductal functioning
[16] at picomolar or nanomolar doses. Taken together,
these observations suggest that pyridine and pyrazine
derivatives impair diverse biological processes either by
affecting different mechanisms that control these different
processes or by acting through one common mechanism
that is fundamental to multiple processes.
The concentrations of several pyrazine derivatives in MS
and SS cigarette smoke were determined by Brunnemann
et al. for a single brand commercial U.S. non-filtered
cigarette [34]. For this particular cigarette type, 2-methyl-
pyrazine was present in the gas phase of MS smoke at 2.2
ppm and in gas phase of SS smoke at 55 ppm [34]. The
combined concentration of 2,3-dimethylpyrazine, 2,5-
dimethylpyrazine, and 2,6-dimethylpyrazine was 3.9
ppm in the gas phase of MS and 61 ppm in gas phase of
Table 1: Pyrazine Derivatives Identified in the Inhibitory Eluates From Three Solid Phase Extraction Cartridges Loaded with MS Smoke
C8a PHb CNc
2-methylpyrazine
2-ethylpyrazine
2,5 dimethylpyrazine
2,6 dimethylpyrazine
2,3,5-trimethylpyrazine
2-methoxy-3-methylpyrazine
a C8: Octyl (8-carbon straight-chain hydrocarbon) b PH: Phenyl c CN: Cyanopropyl
Table 2: LOAELs and Efficacies for Pyrazine Derivatives in the Oviductal Assays
LOAELs (M)a Efficacies (%)b,c
Ciliary Beat 
Frequency
Oocyte Pickup 
Rate
Contraction 
Rate
Chemical Ciliary Beat 
Frequency
Oocyte Pickup 
Rate
Contraction 
Rate
10-12 10-11 10-9 pyrazine 25 29 40
10-12 10-11 10-11 2-methylpyrazine 11* 43* 61**
10-12 10-11 10-12 2-ethylpyrazine 3** 45* 38
10-8 10-11 10-9 2,5-dimethylpyrazine 34 10* 40
10-6 10-9 10-7 2,6-dimethylpyrazine 5** 3** 85***
10-9 10-10 10-9 2,3,5-trimethylpyrazine 18 10* 58**
10-9 10-12 10-12 2-methoxy-3-methylpyrazine 18 13* 17**
a LOAEL is lowest observable adverse effect level b Efficacy is the mean percentage of inhibition at the LOAEL c Student's t-Test was performed on 
efficacies comparing each chemical back to pyrazine for each bioassay. * p < 0.05; ** p < 0.01; *** p < 0.001.
Table 3: Hierarchies of Potency Based on LOAELs for the Oviductal Assays
Ciliary Beat Frequency pyrazine = 2-methylpyrazine = 2-ethylpyrazine > 2-methoxy-3-methylpyrazine = 2,3,5-
trimethylpyrazine > 2,5-dimethylpyrazine > 2,6-dimethylpyrazine
Oocyte Pickup Rate 2-methoxy-3-methylpyrazine > 2-methylpyrazine = 2-ethylpyrazine = pyrazine = 2,5-
dimethylpyrazine > 2,3,5-trimethylpyrazine > 2,6-dimethylpyrazine
Infundibular Smooth Muscle Contraction Rate 2-methoxy-3-methylpyrazine = 2-ethylpyrazine > 2-methylpyrazine > 2,3,5-
trimethylpyrazine = 2,5-dimethylpyrazine = pyrazine > 2,6-dimethylpyrazine
9 9 9
9
9 9
9
9 9 9
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SS smoke. Quantitative analysis of cigarette smoke has
shown that both pyridine and pyrazine compounds are
more concentrated in SS than MS smoke [34]. 2-Methyl-
pyrazine was one of the most potent pyrazine derivatives
in this study, with a LOAEL in several of the bioassays of
10-12 M. The concentrations of pyrazine derivatives in the
serum or tissues of smokers are unknown. However, since
the pyrazine compounds are inhibitory at such low doses,
it is likely that these pyrazine derivatives are present in vivo
at high enough concentrations to adversely affect proc-
esses such as ciliary beat frequency, oocyte pickup, and
smooth muscle contraction.
Pyrazine and the six pyrazine derivatives examined in this
study appear on the FEMA GRAS list of chemicals [28].
This is a list of chemicals published by the Flavor and
Extract Manufacturers' Association (FEMA) that are gener-
ally regarded as safe (GRAS) and are therefore added
directly to food, drinks, tobacco, cosmetics, and fra-
grances. Pyrazines with alkyl and alkoxy substitutions
may also be produced from condensation of hexoses and
amino acids at elevated temperatures. Their precursors are
the amine and carbonyl compounds found in uncooked
foods [28]. Pyrazine derivatives are absorbed optimally at
intestinal pH [28]. The metabolism of pyrazine deriva-
tives involves oxidation of side-chain alkyl or oxygenated
functional groups and hydroxylation of the pyrazine ring
[28].
Pyrazines are responsible for roasted or smoky flavors and
are widely distributed in food products [35]. The range for
the average usual and average maximum concentrations
of pyrazine added to various types of food are (0.3–1.0
ppm) and (1.5–5.0 ppm) respectively [28]. The LOAEL
doses for pyrazine in our study were (0.4 ppb) for the
ciliary beat frequency assay, (4 ppb) for the oocyte pickup
rate assay, and (400 ppb) for the infundibular smooth
muscle contraction assay, which are all less than the con-
centrations of pyrazine added to food. However, the dose
eaten is probably not equivalent to the dose at the
oviduct.
Recently, the safety of pyrazine compounds was re-evalu-
ated for FEMA, and it was concluded that pyrazine com-
pounds are safe for use in human consumer products
[28]. Although many of the biological processes, for
example, acute toxicity, sub-chronic toxicity, histopathol-
ogy, hematology, organ weights, clinical chemistry, geno-
toxicity, hepatotoxicity, and carcinogenicity, were
reviewed and were not significantly affected by pyrazine
compounds, there were reproductive effects shown in sev-
eral of the papers reviewed by Adams et al., [28]. For
example, 2,5-dimethylpyrazine delayed the onset of
puberty in female mice due to effects on adrenal function
[36] and caused a decrease in uterine weight in rats in a
dose-dependent manner, possibly by inhibition of uterine
uptake of estradiol [37]. In male rats, 3,6-dimethylpyra-
zine-2-thiol caused a decrease in prostate and seminal ves-
icle weights [38], and 2,5-dimethylpyrazine decreased
levels of plasma testosterone, polyamines, and acid phos-
phatase in the prostate [39]. Our data show that very low
doses of pyrazine and six of its derivatives adversely affect
various cell processes important in oviductal functioning.
When combined with prior reproductive studies, our
results raise questions about the safety of these com-
pounds in consumer products even at very low doses.
Conclusions
In conclusion, the results of our study show that individ-
ual pyrazine compounds identified in MS and SS smoke
solutions inhibit ciliary beat frequency, oocyte pickup
rate, and infundibular smooth muscle contraction rate at
picomolar and nanomolar doses. Prior studies have
shown that pyrazines also impair growth and angiogen-
esis in CAMs at very low doses. Given the broad spectrum
of effects that pyrazines exhibit in these diverse assays and
their widespread use in consumer products, they may not
be as safe as previously thought and further toxicological
testing of pyrazines should be done.
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